Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients.

Korean Circ J · 2017 · PMC5711674 · PMID 29171208

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

showed a trendno p-value reported

24) reported that, in the propensity weighted Danish nationwide study of reduced-dose NOAC regimens, apixaban 2.5 mg twice a day was associated with an increasing trend of ischemic stroke/systemic embolism rates compared with warfarin, while rivaroxaban 15 mg once a day and dabigatran 110 mg twice a day showed a trend of lower thromboembolic rates.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.